Skip to main content
All lobbying filings

BAYCARE HEALTH SYSTEM

Lobbying for BAYCARE HEALTH SYSTEM

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · Florida · House · Senate · $211,558.00 expenses · posted Nov 5, 2025

Official filing document

 Lobbying activity 3
Medicare/Medicaid

Lobbied against various provisions pertaining to provider taxes, coverage changes, community engagement requirements that would have a detrimental impact to healthcare in Florida contained within the OBBBA. This includes provisions that reduce retroactive coverage and coverage for legally present individuals.

Health Issues

Advocated against proposals to cut Medicaid access and/or reimbursement. Advocated for extension of the Enhanced Premium Tax Credits to ensure Americans have access to health coverage. Advocated for continued support of the 340B drug pricing program. Advocated for extension of telehealth flexibilities and Hospital-at-Home waiver program (AHCAH at CMS). On AHCAH, advocated for extension of current program to include observation patients.

Pharmacy

Advocated for protection of the existing 340B drug pricing program and concerns around a rebate model at HRSA.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem